If you have been reading about 反相色谱 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-12. Numbers and descriptions here follow the published literature rather than marketing material.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
| Property | Value | Notes |
|---|---|---|
| Appearance | white to off-white powder | Lyophilised solid form |
| Solubility | pH dependent; low near pI | Minimum close to pH 5.4 |
| Storage temperature | -20 C solid; 2-8 C solution | Protect from light |
| Isoelectric point | approx. pH 5.4 | Controls solubility minimum |
| Common analytical method | RP-HPLC with mass detection | Purity and identity checks |
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Philosophy of technology is a branch of philosophy that studies the "practice of designing and creating artifacts", and the "nature of the things so created". It emerged as a discipline over the past two centuries, and has grown "considerably" since the 1970s. The humanities philosophy of technology is concerned with the "meaning of technology for, and its impact on, society and culture". Initially, technology was seen as an extension of the human organism that replicated or amplified bodily and mental faculties. Marx framed it as a tool used by capitalists to oppress the proletariat, but believed that technology would be a fundamentally liberating force once it was "freed from societal deformations". Second-wave philosophers like Ortega later shifted their focus from economics and politics to "daily life and living in a techno-material culture", arguing that technology could oppress "even the members of the bourgeoisie who were its ostensible masters and possessors". Third-stage philosophers like Don Ihde and Albert Borgmann represent a turn toward de-generalization and empiricism, and considered how humans can learn to live with technology. Early scholarship on technology was split between two arguments: technological determinism and social construction. Technological determinism is the idea that technologies cause unavoidable social changes. It usually encompasses a related argument, technological autonomy, which asserts that technological progress follows a natural progression and cannot be prevented.
After fierce fighting erupted between the Druze and Maronite populations in the Mount Lebanon region in 1860, France and other Western nations then pressured the Ottomans to set up a semiautonomous region known as a Mutasarrifate. After 1861 there existed an autonomous Mount Lebanon with a Christian mutasarrıf, which had been created as a homeland for the Maronites under European diplomatic pressure following the 1860 massacres. Historians link the Maronite ascendancy in the Mutasarrifate to their alliance with the French and their subsequent domination of the silk trade, through the development of a Maronite bourgeoisie class. The Maronite Catholics and the Druze founded modern Lebanon in the early eighteenth century, through the ruling and social system known as the "Maronite-Druze dualism" which developed in Ottoman-era Mount Lebanon Mutasarrifate, creating one of the calmest atmospheres that Lebanon had ever lived in. The working out of this dualism greatly affected the character of independent Lebanon later. Upon the establishment of the Mutasarrifate system, the Christians and Druze groups entered in economic, political, and religious relations with Europeans rather than Ottomans. The ruling and social system in the Mount Lebanon Mutasarrifate was formed from the Maronite-Druze dualism, and the security stability and Druze-Maronite coexistence in the Mutasarrifate allowed the development of the economy and the system of government.
==== Ebola treatment ==== In 2014, the FDA added an Ebola treatment being developed by Canadian pharmaceutical company Tekmira to the Fast Track program, but halted the phase 1 trials in July pending the receipt of more information about how the drug works. This was widely viewed as increasingly important in the face of a major outbreak of the disease in West Africa that began in late March 2014 and ended in June 2016.
Sources: en.wikipedia.org
== External links == Zostavax Product Page U.S. Food and Drug Administration (FDA) Shingrix Product Page U.S. Food and Drug Administration (FDA) "Shingrix Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 15 January 2025. "Zostavax (Herpes Zoster Vaccine) Questions and Answers". Questions about Vaccines. U.S. Food and Drug Administration (FDA). 18 February 2021. Clinical trial number NCT02723773 for "A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults" at ClinicalTrials.gov
Evidence from systematic reviews suggests that interventions such as farm biosecurity and water, sanitation, and hygiene (WASH) practices may reduce antimicrobial use and contribute to limiting the development and spread of resistance.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) is a scientific committee for defining guidelines to interpret antimicrobial resistance. It was formed in 1997 and is jointly organized by ESCMID, ECDC and other European laboratories. EUCAST guidelines are one of the most popular breakpoint guidelines used in antimicrobial susceptibility testing worldwide. The EUCAST guidelines are freely available to all of their users. Like the Clinical and Laboratory Standards Institute, EUCAST offers guidelines to interpret raw minimum inhibitory concentrations (MICs), the lowest concentration of a chemical, usually a drug, which prevents visible growth of bacterium. The interpretation to antimicrobial resistance (reported as "R") or antimicrobial susceptibility (reported as "S") differs for all bug-drug combinations which is why guidelines are needed.
=== Stress and anxiety === In vitro studies examining the effects of CRH1 antagonists on the hypothalamic–pituitary–adrenal axis showed that antalarmin inhibited ACTH release in rat anterior pituitary cells, as well as inhibited cortisol synthesis and release in human adrenal cells. In vivo studies revealed that pre-treating rats with antalarmin inhibited increases in plasma ACTH following CRH injection (i.v.), with no effect on baseline levels. However, another study demonstrated that 8 weeks of antalarmin administered twice daily (i.p.) in rats significantly lowered basal ACTH and corticosterone levels, resulting in reduced adrenocortical responsiveness to ACTH. When antalarmin was administered to primates, it also inhibited increases in plasma ACTH, as well as prevented the anxiety response produced by a social stressor (e.g. presentation of another male in an unfamiliar environment). With regards to neurochemical effects, antalarmin has been shown to inhibit increases in extracellular cortical norepinephrine induced by rat tail pinch, suggesting that CHR1 receptors may be implicated in stress-evoked norepinephrine release in the cortex. Antalarmin was also shown to have electrophysiological effects by partially reversing the inhibition of neuronal firing in the dorsal raphe nucleus that occurs following intracerebroventricular (i.c.v) administration of CRH. Studies using CRH receptor antagonists such as antalarmin in anxiety models have shown that these agents produce effects similar to clinically effective anxiolytics.
Sources: en.wikipedia.org
Crucially, investigations confirmed that Kambolina had absolutely no involvement with the "Blue Whale Challenge" or online "death groups", as they did not exist at the time of her passing. Instead, her story and imagery were retroactively co-opted and weaponised by predatory online administrators to orchestrate a widespread moral panic, fabricate the mythos of a centralized "suicide game", and draw susceptible teenagers into harmful online communities.
Buffalo General Medical Center-Located on the Buffalo Niagara Medical Campus, Buffalo General Medical Center offers a wide spectrum of clinical inpatient and outpatient treatment programs. John R. Oishei Children's Hospital-This regional center for specialized pediatric and women's health care has achieved national recognition and is ranked among the top 20 pediatric hospitals in the nation by U.S. News & World Report. Millard Fillmore Suburban Hospital- this 200-bed community hospital supports residency training programs in anesthesiology, emergency medicine, general surgery, urology, obstetrics and gynecology, and family practice. DeGraff Memorial Hospital-A 70-bed community hospital primarily serving the needs of patients in towns north of Buffalo. Erie County Medical Center-This 550-bed medical center serves as a regional center for trauma, burns, rehabilitation and cardiac care. Veterans Affairs Western New York Healthcare System-The Buffalo VA Medical Center provides inpatient and outpatient programs. It is the main referral center for cardiac surgery, cardiology and comprehensive cancer care for Western New York and northern Pennsylvania. Sisters of Charity Hospital- Buffalo's first hospital and a Designated Stroke Center, Sisters of Charity Hospital serves patients in its inpatient and outpatient facilities. Mercy Hospital of Buffalo-Mercy Hospital is a Center of Excellence for Stroke and Cardiac Care. It recently revamped emergency department is a model for emergency health-care treatment.
=== N05AA Phenothiazines with aliphatic side-chain === N05AA01 Chlorpromazine N05AA02 Levomepromazine N05AA03 Promazine N05AA04 Acepromazine N05AA05 Triflupromazine N05AA06 Cyamemazine N05AA07 Chlorproethazine
Sources: en.wikipedia.org
Solid material is normally kept frozen at about -20 degrees Celsius, desiccated and protected from light. Solutions are held cold and used within a defined window because degradation products accumulate over time.
Mass spectrometry, usually electrospray ionisation coupled to liquid chromatography, gives an observed mass for comparison with the theoretical value. Peptide mapping after digestion provides complementary sequence-level confirmation.
Short exposure during weighing and handling is generally tolerated, but prolonged storage above refrigerated conditions raises the risk of deamidation, oxidation, and aggregation. The rate depends on pH, buffer composition, and concentration.
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.